Analyses of odontogenic tumoursthe most recent classification proposed by the World Health Organization (2017)

  1. Kevin Barrios-Garay 1
  2. Luisa-Fernanda Agudelo-Sánchez 1
  3. José Manuel Aguirre Urizar 2
  4. Cosme Gay-Escoda 3
  1. 1 Dentistry student. Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
  2. 2 MD, DDS, PhD. Chairman and Professor of Oral Medicine, Stomatology II Department, Faculty of Medicine and Nursery, University of the Basque Country/EHU, Leioa, Spain
  3. 3 MD, DDS, MS, PhD, EBOS, OMFS. Chairman and Professor of Oral and Maxillofacial Surgery, Faculty of Medicine and Health Sciences, University of Barcelona. Director of the Master’s Degree Programme in Oral Surgery and Implantology (EHFRE International University/FUCSO). Coordinator/Researcher at the IDIBELL Institute. Head of the Oral Surgery, Implantology and Maxillofacial Surgery Department of the Teknon Medical Centre, Barcelona, Spain
Mostrar afiliaciones +
Revista:
Medicina oral, patología oral y cirugía bucal. Ed. inglesa

ISSN: 1698-6946

Año de publicación: 2020

Volumen: 25

Número: 6

Páginas: 14

Tipo: Artículo

DOI: 10.4317/MEDORAL.23751 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Medicina oral, patología oral y cirugía bucal. Ed. inglesa

Resumen

The fourth edition of the ‘’WHO Classification of Head and Neck Tumours’’ was published in January 2017 and includes a classification of odontogenic tumours. This review aims to examine the changes made in this new classification in comparison with the previous classification of 2005. An electronic search was conducted in the PubMed, Scopus and Cochrane databases with the keywords “odontogenic tumor”, “WHO classification” and “update”. Studies published from January 2009 to April 2019 with a high level of scientific evidence were included, but studies not published in English, epidemiological studies and studies with a low level of evidence were excluded. The initial search found 457 articles and after eliminating duplicates, 8 studies were selected for full-text assessment. After excluding 3 epidemiological studies, 5 articles were finally included. These studies were stratified by their level of scientific evidence using SORT criteria (Strength of Recommendation Taxonomy). The new odontogenic tumour list has been simplified with the objective of improving its role as an international guide for diagnosis. Some changes have been possible thanks to the application of immunohistochemistry and molecular genetic techniques that allow better characterization of certain tumours. Further clinicopathological and molecular studies are needed so that this new classification can be consolidated and/or amended.

Referencias bibliográficas

  • El-Naggar, AK,Chan, JKC,Grandis, JR,Takata, T,Slootweg, P. (2017). WHO classification of head and neck tumours. 4th ed. IARC Press. Lyon.
  • Pindborg, JJ,Kramer, IRH,Torloni, H. (1971). WHO histological typing of odontogenic tumours, jaw cysts, and allied lesions. World Health Organization. Geneva.
  • Kramer, IRH,Pindborg, JJ,Shear, M. (1992). WHO histological typing of odontogenic tumors. 2nd ed. Springer-Verlag. Berlin.
  • Barnes, L,Eveson, J,Reichart, P,Sidransky, D. (2005). World Health Organization classification. Pathology and genetics of head and neck tumors. 3rd ed. IARC Press. Lyon.
  • Wright, JM,Odell, E,Speight, PM,Takata, T. (2014). Odontogenic tumors, WHO 2005: Where do we go from here?. Head Neck Pathol. 8. 373
  • Wright, JM,Vered, M. (2017). Update from the 4th Edition of the World Health Organization classification of head and neck tumours: Odontogenic and maxillofacial bone tumors. Head Neck Pathol. 11. 68-77
  • Kennedy, RA. (2018). WHO is in and WHO is out of the mouth, salivary glands, and jaws section of the 4th edition of the WHO classification of head and neck tumours. Br J Oral Maxillofac Surg. 56. 90
  • Ebell, MH,Siwek, J,Weiss, BD,Woolf, SH,Susman, J,Ewingman, B. (2004). Strength of recommendation taxonomy (SORT): A patient centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 17. 59-67
  • Moher, D,Liberati, A,Tetzlaff, J,Altman, DG. (2009). The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoSMed. 6. 1000097
  • Koutlas, IG,Allen, CM,Warnock, GR,Manivel, JC. (2008). Sclerosing odontogenic carcinoma: A previously unreported variant of a locally aggressive odontogenic neoplasm without apparent metastatic potential. Am J Surg Pathol. 39. 1613
  • Ide, F,Kikuchi, K,Kusama, K. (2011). Sclerosing odontogenic carcinoma. Pathol Int. 61. 259
  • Hussain, O,Rendon, AT,Orr, RL,Speight, PM. (2013). Sclerosing odontogenic carcinoma in the maxilla: A rare primary intraosseous carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 116. 283
  • Mosqueda-Taylor, A,Pires, FR,Aguirre-Urízar, JM,Carlos-Bregni, R,de la Piedra-Garza, JM,Martínez-Conde, R. (2014). Primordial odontogenic tumour: Clinicopathological analysis of six cases of a previously undescribed entity. Histopathology. 65. 606
  • Lei, Y,Jaradat, JM,Owosho, A,Adebiyi, KE,Lybrand, KS,Neville, BW. (2014). Evaluation of SOX2 as a potential marker for ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 117. 608
  • Richardson, MS,Muller, S. (2014). Malignant odontogenic tumors: An update on selected tumors. Head Neck Pathol. 8. 411
  • Gong, Y,Wang, L,Wang, H,Li, T,Chen, X. (2009). The expression of NF-κβ, Ki-67 and MMP-9 in CCOT, DGCT and GCOC. Oral Oncol. 45. 515
  • Yancoskie, AE,Sreekantaiah, C,Jacob, J,Rosenberg, A,Edelman, M,Antonescu, CR. (2014). EWSR1 and ATF1 rearrangements in clear cell odontogenic carcinoma: Presentation of a case. Oral Surg Oral Med Oral Pathol Oral Radiol. 118. 115
  • Mosqueda-Taylor, A,Neville, BW,Tatemoto, Y,Ogawa, I,Takata, T. (2014). Odontogenic carcinoma with dentinoid: A new odontogenic carcinoma. Head Neck Pathol. 8. 421
  • Chikosi, R,Segall, N,Augusto, P,Freedman, P. (2011). Odontogenic carcinosarcoma: Case, report and literature review. J Oral Maxillofac Surg. 69. 1501
  • Sweeney, RT,McClary, AC,Myers, BR,Biscocho, J,Neahring, L,Kwei, KA. (2014). Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 46. 722
  • Kurppa, KF,Caton, J,Morgan, PR,Ristimaki, A,Ruhin, B,Kellokoski, J. (2014). High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 232. 492
  • Diniz, MG,Gomes, CC,Guimarães, BV,Castro, WH,Lacerda, JC,Cardoso, SV. (2015). Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Tumour Biol. 36. 5649
  • Pereira, NB,Pereira, KM,Coura, BP,Diniz, MG,de Castro, WH,Gomes, CC. (2016). BRAFV600E mutation in the diagnosis of unicystic ameloblastoma. J Oral Pathol Med. 45. 780
  • Dissanayake, RK,Jayasooriya, PR,Siriwardena, DJ,Tilakaratne, WM. (2011). Review of metastasizing (malignant) ameloblastoma (METAM): Pattern of metastasis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 111. 734
  • Kaye, FJ,Ivey, AM,Drane, WE,Mendehall, WM,Allam, RW. (2015). Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst. 107. 378
  • Broudic, M,Blay, JY,Vazquez, L,Evrard, A,Karanian, M,Taïeb, S. (2019). Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: A case report. J Med Case Rep. 13. 245
  • Buchner, A,Vered, M. (2013). Ameloblastic fibroma: A stage in the development of a hamartomatous odontoma or a true neoplasm? Critical analysis of 162 previously reported cases plus 10 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 116. 598-606
Fuente de los datos: Dialnet